Meloxicam Rompharm

Meloxicam, the active ingredient in Meloxicam Rompharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It treats pain and inflammatory conditions such as rheumatoid arthritis and osteoarthritis in adult patients.

GNH USA supplies Meloxicam Rompharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in musculoskeletal disorders.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint pain and stiffness. - Acute pain: provides analgesic relief for short‑term pain episodes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection‑site pain or erythema. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Hepatic dysfunction: elevated transaminases or hepatitis. - Renal impairment: acute kidney injury or worsening chronic kidney disease.

When using Meloxicam, clinicians should consider several safety measures.

- Assess renal function: avoid or adjust use in patients with significant renal impairment. - Monitor hepatic function: contraindicated in severe liver disease. - Avoid in known hypersensitivity to meloxicam or other NSAIDs. - Use caution in cardiovascular disease: increased risk of thrombotic events. - Pregnancy and lactation: prescribe only if clearly needed after risk‑benefit assessment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: potential for renal impairment. - Lithium: NSAIDs can raise lithium serum concentrations.